Table 1.
Source | Cargo | Target cells | Function | Reference |
---|---|---|---|---|
Parasite: schistosome |
Metabolic enzymes | Host cells | Metabolic processes | (38) |
Signal proteins | Signal transduction | (38) | ||
Schistosomal antigens | Potential therapeutic targets | (63) | ||
Transport and storage proteins | Obtain nutrients | (41, 43) | ||
Exosomal markers | Potential therapeutic strategy | (37, 41) | ||
Proteasome | Potential therapeutic targets | (37) | ||
Biological process | ||||
N-glycans | moDCs | DC maturation and cytokines release | (58) | |
Bantam miRNAs | Macrophages | Promote inflammatory responses | (64) | |
Host cells | Potential therapeutic strategy | (37) | ||
Macrophages | Promote inflammatory responses | (64) | ||
miR-10 | T helper cells | Downregulate Th2 immune response | (55) | |
miR-148a | Macrophages | Reduce macrophage polarization | (65) | |
sja-miR-3096 | Hepatoma cells | Inhibits proliferation and migration of hepatoma cells | (66) | |
sja-miR-2162 | HSC | Activation and fibrogenesis | (67) | |
sja-miR-1 | HSC | Activation and fibrogenesis | (68) | |
sja-miR-71a | HSC | Inhibit Activation and fibrogenesis | (69) | |
LPC, PGD2 | Eosinophils | Promote hepatic tissue repair | (70) | |
Host hUCMSC | Not studied | HSC | Reduce HSC activation and liver injury | (71) |
Host DCs | Not studied | Not studied | Reduce inflammation responses | (72) |
DC, dendritic cells; HSC, hepatic stellate cell; hUCMSC, human umbilical cord mesenchymal stem cells; LPC, lysophosphatidylcholine; miR/miRNA, micro ribonucleic acid; PGD2, prostaglandin-D2; sja, Schistosoma japonicum.